- Home
- AUST vs AIDX Comparison
AUST vs AIDX Comparison
Compare AUST & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUST | AIDX |
|---|---|---|
| Founded | 2020 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.1M | 19.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUST | AIDX |
|---|---|---|
| Price | $1.48 | $2.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 124.6K | ★ 158.6K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.08 | $1.51 |
| 52 Week High | $3.92 | $14.09 |
Technical Indicators
Market Signals| Indicator | AUST | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.20 | 16.86 |
| Support Level | $1.44 | $1.51 |
| Resistance Level | $1.66 | N/A |
| Average True Range (ATR) | 0.11 | 0.25 |
| MACD | 0.03 | 0.28 |
| Stochastic Oscillator | 67.74 | 49.71 |
Price Performance
Historical ComparisonAbout AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration, and evaluation of mineral resource properties in the western United States of America (USA). The exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek, Lone Mountain, Stockade Mountain, Fourmile Basin, and Miller.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.